UAB "Nobel Biocare" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data
| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 1,918,756 |
| 181,873 |
| 16,702 |
| 16,001 |
| 1,517 |
| 37.28 |
| 0.83 |
| 739,183 |
| 730,130 |
| 29,268 |
| 1,486,100 |
| 2023 |
|---|
| 2,446,261 |
| 212,718 |
| 70,637 |
| 62,993 |
| 5,478 |
| 43.64 |
| 2.58 |
| 796,563 |
| 1,092,963 |
| 38,634 |
| 1,935,078 |
| 2024 |
|---|
| 2,098,995 |
| 185,588 |
| -46,139 |
| -42,779 |
| -3,782 |
| 42.68 |
| -2.04 |
| 795,868 |
| 724,687 |
| 38,251 |
| 1,559,790 |
Register and
explore Okredo data| 2024 |
|---|
| 2,098,995 |
| 185,588 |
| -46,139 |
| -42,779 |
| -3,782 |
| 42.68 |
| -2.04 |
| 795,868 |
| 724,687 |
| 38,251 |
| 1,559,790 |
Register and
explore Okredo data2024
Turnover (€)
2,098,995 €
-14 % *
Sales per employee (€)
185,588 €-13 % *
Profit before tax (€)
-46,139 €-165 % *
Net Profit (€)
-42,779 €-168 % *
Profit per employee (€)
-3,782 €-169 % *
Total profitability (%)
42.68 %-2.20 % *
Net profitability (%)
-2.04 %-179.07 % *
Equity (€)
795,868 €0 % *
Amounts Payable And Liabilities (€)
724,687 €
-34 % *
Non-current Assets (€)
38,251 €-1 % *
CurrentAssets (€)
1,559,790 €-19 % *